Celldex Therapeutics, Inc. (CLDX) vs GeneDx Holdings Corp. (WGS)
A side-by-side comparison of Celldex Therapeutics, Inc. and GeneDx Holdings Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLDX
Celldex Therapeutics, Inc.
$31.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WGS
GeneDx Holdings Corp.
$71.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CLDX vs WGS
growth of $100 · dividends reinvested · last 6yCLDX +112.0% (+13.3%/yr)WGS -76.4% (-21.4%/yr)CLDX compounded faster over this window
Log scale — wide-divergence pair
CLDX WGS
CLDX vs WGS: by the numbers
- •WGS is the larger company ($2.13B vs $2.06B market cap).
- •Both run net losses; WGS's is the smaller (-23.40% vs -268385.71% net margin).
- •WGS grew revenue faster over the past five years (16.28% vs -58.05% CAGR).
Metrics side by side
Valuation
| Metric | CLDX | WGS |
|---|---|---|
| P/S ratio | 18419.87 | 4.69 |
| P/B ratio | 2.89 | 8.73 |
Profitability
| Metric | CLDX | WGS |
|---|---|---|
| Gross margin | 100.00% | 68.20% |
| Operating margin | -19160.00% | -2.76% |
| Net margin | -268385.71% | -23.40% |
| ROE | -42.07% | -43.55% |
| ROIC | -45.19% | -14.69% |
Growth (annualized)
| Metric | CLDX | WGS |
|---|---|---|
| Revenue CAGR (5Y) | -58.05% | 16.28% |
| Total return CAGR (5Y) | -10.28% | -19.67% |
Frequently asked
- Which has grown faster, CLDX or WGS?
- Over the past five years, WGS grew revenue faster — CLDX at a -58.05% CAGR versus WGS at 16.28%.
- How have CLDX and WGS total returns compared?
- Over the past 5 years, CLDX delivered -10.28% and WGS delivered -19.67% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Celldex Therapeutics ROEGeneDx ROECelldex Therapeutics operating marginGeneDx operating marginCelldex Therapeutics revenue growthGeneDx revenue growthCelldex Therapeutics free cash flowGeneDx free cash flow
Celldex Therapeutics & GeneDx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.